<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: DeepCurrents Investment Group LLC -->
          <cik>0001754535</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock, $0.0001 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/30/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001728117</issuerCik>
        <issuerName>Gossamer Bio, Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>38341P102</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>3115 Merryfield Row</com:street1>
          <com:street2>Suite 120</com:street2>
          <com:city>San Diego</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92121</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>DeepCurrents Investment Group LLC</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>177975.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>242437.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>242437.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>3.8</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
      <comments>(1) The figure in Item 6 represents shares of Common Stock, $0.0001 par value per share ("Common Stock") of Gossamer Bio, Inc. (the "Issuer") that may be acquired by the DCIG Capital Master Fund LP, a Cayman Islands limited partnership (the "Fund") within 60 days pursuant to warrants held by the Fund.

(2) The figures in Items 8 and 9 represent: (a) 177,975 shares of Common Stock that may be acquired by the Fund within 60 days pursuant to warrants held by the Fund, and (b) 64,462 shares of Common Stock that may be acquired by a separately managed account within 60 days pursuant to warrants held by a separately managed account. See Item 2 for more information.

(3) The figure in Item 11 is based upon (i) 242,437 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the conversion of warrants held by the Reporting Persons; and (ii) 6,116,390 shares of Common Stock outstanding as of November 7, 2026, as disclosed on the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed with the U.S. Securities and Exchange Commission (the "SEC") on November 10, 2026.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>DCIG GP LLC</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>177975.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>177975.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>177975.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>2.9</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>(1) The figures in Items 6, 8, and 9 represent Common Stock that may be acquired by the Reporting Persons within 60 days pursuant to warrants held by the Reporting Persons.

(2) The figure in Item 11 is based upon (i) 177,975 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the conversion of the warrants held by the Reporting Persons; and (ii) 6,116,390 shares of Common Stock outstanding as of November 7, 2026, as disclosed on the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed with the SEC on November 10, 2026.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>DCIG Capital Master Fund LP</reportingPersonName>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>177975.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>177975.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>177975.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>2.9</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>(1) The figures in Items 6, 8, and 9 represent Common Stock that may be acquired by the Reporting Persons within 60 days pursuant to warrants held by the Reporting Persons.

(2) The figure in Item 11 is based upon (i) 177,975 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the conversion of the warrants held by the Reporting Persons; and (ii) 6,116,390 shares of Common Stock outstanding as of November 7, 2026, as disclosed on the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed with the SEC on November 10, 2026.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Kai Zheng</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>177975.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>242437.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>242437.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>3.8</classPercent>
      <typeOfReportingPerson>HC</typeOfReportingPerson>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>(1) The figure in Item 6 represents shares of Common Stock that may be acquired by the Fund within 60 days pursuant to warrants held by the Fund.

(2) The figures in Items 8 and 9 represent: (a) 177,975 shares of Common Stock that may be acquired by the Fund within 60 days pursuant to warrants held by the Fund, and (b) 64,462 shares of Common Stock that may be acquired by a separately managed account within 60 days pursuant to warrants held by a separately managed account. See Item 2 for more information.

(3) The figure in Item 11 is based upon (i) 242,437 shares of Common Stock that may be acquired by the Reporting Persons within 60 days upon the conversion of the warrants held by the Reporting Persons; and (ii) 6,116,390 shares of Common Stock outstanding as of November 7, 2026, as disclosed on the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed with the SEC on November 10, 2026.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Gossamer Bio, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>3115 Merryfield Row Suite 120 San Diego, CA, 92121</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This statement is filed jointly by and on behalf of each of DeepCurrents Investment Group, LLC, a Delaware limited liability company ("DeepCurrents"), DCIG Capital Master Fund LP, a Cayman Islands limited partnership (the "Fund"), DCIG GP LLC, a Delaware limited liability company ( "DeepCurrents GP"), and Kai Zheng (each, a "Reporting Person" and collectively, the "Reporting Persons"). DeepCurrents is the investment manager of, and may be deemed to indirectly beneficially own securities owned by, the Fund. DeepCurrents is also an investment adviser to a separately managed account of an advisory client (the "Managed Account") and may be deemed to beneficially own securities directly in the Managed Account, but DeepCurrents does not have any voting authority with respect to any securities in the Managed Account. DeepCurrents GP is the general partner of, and may be deemed to indirectly beneficially own securities owned by, the Fund. Mr. Zheng is the President and Managing Member of DeepCurrents and Managing Member of DeepCurrents GP, and may be deemed to indirectly beneficially own securities beneficially owned by DeepCurrents and DeepCurrents GP. The Fund and the Managed Account are the record and direct beneficial owners of the shares of Common Stock covered by this statement. Each Reporting Person disclaims beneficial ownership of the shares of Common Stock held directly by the other Reporting Persons. The Managed Account disclaims beneficial ownership of the shares of Common Stock held directly by the Reporting Persons. Each Reporting Person disclaims beneficial ownership of the shares of Common Stock held directly by the Managed Account.

Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such Reporting Person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, the beneficial owner of any securities covered by this statement.

Each Reporting Person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for the purposes of Section 13(d) or 13(g) of the Act. Each of the Reporting Persons declares that neither the filing of this statement nor anything herein shall be construed as an admission that such Reporting Person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The address of the principal business office of each of the Reporting Persons is 575 Fifth Avenue, 21st Floor, New York, NY 10017.</principalBusinessOfficeOrResidenceAddress>
        <citizenship>See Item 4 on the cover page(s) hereto.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>See Item 9 on the cover pages(s) hereto.</amountBeneficiallyOwned>
        <classPercent>See Item 11 on the cover page(s) hereto.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>See Item 5 on the cover pages hereto.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>See Item 6 on the cover pages hereto.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>See Item 7 on the cover pages hereto.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>See Item 8 on the cover pages hereto.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>N</notApplicableFlag>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.</certifications>
      </item10>
    </items>
    <exhibitInfo>Exhibit 99.1 - Joint Filing Agreement (incorporated herein by reference to Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons with the SEC on June 11, 2026).</exhibitInfo>
    <signatureInformation>
      <reportingPersonName>DeepCurrents Investment Group LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Kai Zheng</signature>
        <title>Kai Zheng, Managing Member and President</title>
        <date>11/16/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>DCIG GP LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Kai Zheng</signature>
        <title>Kai Zheng, Managing Member</title>
        <date>11/16/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>DCIG Capital Master Fund LP</reportingPersonName>
      <signatureDetails>
        <signature>DCIG GP LLC</signature>
        <title>General Partner</title>
        <date>11/16/2026</date>
      </signatureDetails>
      <signatureDetails>
        <signature>/s/ Kai Zheng</signature>
        <title>Kai Zheng, Managing Member</title>
        <date>11/16/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Kai Zheng</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Kai Zheng</signature>
        <title>Kai Zheng</title>
        <date>11/16/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
